Abbott Laboratories Stock Buy Hold or Sell Recommendation
| ABT Stock | USD 135.82 0.87 0.64% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Abbott Laboratories is 'Strong Buy'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Abbott Laboratories given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Abbott Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Abbott Laboratories Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide. Note, we conduct extensive research on individual companies such as Abbott and provide practical buy, sell, or hold advice based on investors' constraints. Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Abbott |
Execute Abbott Laboratories Buy or Sell Advice
The Abbott recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Abbott Laboratories. Macroaxis does not own or have any residual interests in Abbott Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Abbott Laboratories' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Abbott Laboratories Trading Alerts and Improvement Suggestions
| Over 79.0% of the company shares are held by institutions such as insurance companies | |
| On 14th of February 2025 Abbott Laboratories paid $ 0.59 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Distributor Purchasing Shifts Mar MDTs Q3 Show How to Play the Stock |
Abbott Laboratories Returns Distribution Density
The distribution of Abbott Laboratories' historical returns is an attempt to chart the uncertainty of Abbott Laboratories' future price movements. The chart of the probability distribution of Abbott Laboratories daily returns describes the distribution of returns around its average expected value. We use Abbott Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Abbott Laboratories returns is essential to provide solid investment advice for Abbott Laboratories.
| Mean Return | 0.24 | Value At Risk | -1.65 | Potential Upside | 2.53 | Standard Deviation | 1.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Abbott Laboratories historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Abbott Stock Institutional Investors
The Abbott Laboratories' institutional investors refer to entities that pool money to purchase Abbott Laboratories' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Bank Of America Corp | 2024-12-31 | 18.8 M | Wells Fargo & Co | 2024-12-31 | 16.7 M | Bank Of New York Mellon Corp | 2024-12-31 | 13.6 M | State Farm Mutual Automobile Ins Co | 2024-12-31 | 13.6 M | Charles Schwab Investment Management Inc | 2024-12-31 | 12.9 M | Ameriprise Financial Inc | 2024-12-31 | 12.9 M | Massachusetts Financial Services Company | 2024-12-31 | 12.8 M | Polen Capital | 2024-12-31 | 12.7 M | Deutsche Bank Ag | 2024-12-31 | 12.4 M | Vanguard Group Inc | 2024-12-31 | 168.6 M | Blackrock Inc | 2024-12-31 | 136.5 M |
Abbott Laboratories Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (493M) | (456M) | (1.4B) | (232M) | (58M) | (60.9M) | |
| Change In Cash | 3.0B | 3.0B | 83M | (3.0B) | 720M | 756M | |
| Free Cash Flow | 5.7B | 8.6B | 7.8B | 5.1B | 8.6B | 9.0B | |
| Depreciation | 3.3B | 3.5B | 3.3B | 3.2B | 3.2B | 1.9B | |
| Other Non Cash Items | 425M | 55M | 215M | 126M | (8.7B) | (9.2B) | |
| Dividends Paid | 2.6B | 3.2B | 3.3B | 3.6B | 3.8B | 4.0B | |
| Capital Expenditures | 2.2B | 1.9B | 1.8B | 2.2B | 2.2B | 1.3B | |
| Net Income | 4.5B | 7.1B | 6.9B | 5.7B | 13.4B | 14.1B | |
| End Period Cash Flow | 6.8B | 9.8B | 9.9B | 6.9B | 7.6B | 4.2B | |
| Change To Netincome | 582M | 546M | 640M | 685M | 787.8M | 827.1M | |
| Investments | (73M) | (96M) | (33M) | (2.9B) | (2.3B) | (2.2B) | |
| Change Receivables | (275M) | (924M) | (383M) | (68M) | (61.2M) | (64.3M) | |
| Net Borrowings | (1.6B) | (50M) | (248M) | 47M | 42.3M | 40.2M |
Abbott Laboratories Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Abbott Laboratories or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Abbott Laboratories' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Abbott stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.46 | |
σ | Overall volatility | 1.30 | |
Ir | Information ratio | 0.18 |
Abbott Laboratories Volatility Alert
Abbott Laboratories has relatively low volatility with skewness of 0.77 and kurtosis of 2.29. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Abbott Laboratories' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Abbott Laboratories' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Abbott Laboratories Fundamentals Vs Peers
Comparing Abbott Laboratories' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Abbott Laboratories' direct or indirect competition across all of the common fundamentals between Abbott Laboratories and the related equities. This way, we can detect undervalued stocks with similar characteristics as Abbott Laboratories or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Abbott Laboratories' fundamental indicators could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Abbott Laboratories to competition |
| Fundamentals | Abbott Laboratories | Peer Average |
| Return On Equity | 0.31 | -0.31 |
| Return On Asset | 0.0606 | -0.14 |
| Profit Margin | 0.32 % | (1.27) % |
| Operating Margin | 0.19 % | (5.51) % |
| Current Valuation | 241.1 B | 16.62 B |
| Shares Outstanding | 1.73 B | 571.82 M |
| Shares Owned By Insiders | 0.86 % | 10.09 % |
| Shares Owned By Institutions | 79.25 % | 39.21 % |
| Number Of Shares Shorted | 18.24 M | 4.71 M |
| Price To Earning | 24.14 X | 28.72 X |
| Price To Book | 4.91 X | 9.51 X |
| Price To Sales | 5.62 X | 11.42 X |
| Revenue | 41.95 B | 9.43 B |
| Gross Profit | 23.31 B | 27.38 B |
| EBITDA | 6.83 B | 3.9 B |
| Net Income | 13.4 B | 570.98 M |
| Cash And Equivalents | 9.88 B | 2.7 B |
| Cash Per Share | 5.68 X | 5.01 X |
| Total Debt | 20.86 B | 5.32 B |
| Debt To Equity | 0.46 % | 48.70 % |
| Current Ratio | 1.86 X | 2.16 X |
| Book Value Per Share | 27.52 X | 1.93 K |
| Cash Flow From Operations | 8.56 B | 971.22 M |
| Short Ratio | 2.57 X | 4.00 X |
| Earnings Per Share | 7.64 X | 3.12 X |
| Price To Earnings To Growth | 2.43 X | 4.89 X |
| Target Price | 133.08 | |
| Number Of Employees | 114 K | 18.84 K |
| Beta | 0.74 | -0.15 |
| Market Capitalization | 235.56 B | 19.03 B |
| Total Asset | 81.41 B | 29.47 B |
| Retained Earnings | 47.26 B | 9.33 B |
| Working Capital | 9.5 B | 1.48 B |
Note: Disposition of 23771 shares by Daniel Salvadori of Abbott Laboratories at 38.4 subject to Rule 16b-3 [view details]
Abbott Laboratories Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Abbott . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Abbott Laboratories Buy or Sell Advice
When is the right time to buy or sell Abbott Laboratories? Buying financial instruments such as Abbott Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.